Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Evan B. Krisch"'
Autor:
Igor Dumbadze, Kimberley Rieger-Christ, Todd M. Waldmann, John W. Scott, Kenneth B. Deck, Neal D. Shore, John J. Munoz, Richard D. David, James S. Cochran, Evan B. Krisch, James Bailen, Christopher Michael Pieczonka, Raoul S. Concepcion, Timothy Dean Langford, Scott Asroff, Dipen J. Parekh, Fredrick N. Wolk, Daniel Sjöberg, Michael S. Grable, Ralph Jonathan Henderson, Michael Gambla, Shawn M. McGee, Daniel Saltzstein, Lawrence Karsh, Sanoj Punnen, Daniel W. Lin, Stephen M. Zappala, Paul Sieber
Publikováno v:
European urology. 68(3)
Background The 4Kscore combines measurement of four kallikreins in blood with clinical information as a measure of the probability of significant (Gleason ≥7) prostate cancer (PCa) before prostate biopsy. Objective To perform the first prospective
Publikováno v:
Urology. 58:752-755
Objectives. To evaluate two methods of measuring the prostate volume using transrectal ultrasonography. The measurements were performed in vivo at preplanning and again preoperatively in connection with brachytherapy. The accurate measurement of the
Publikováno v:
Medical Physics. 24:1141-1145
A new method of treatment planning for the I-125 and Pd-103 permanent interstitial prostate implant is developed, which does not use the traditional nomograms but automatically generates optimized source configurations. An iterative algorithm is used
Treatment of recurrent urinary tract infection with norfloxacin versus trimethoprim-sulfamethoxazole
Autor:
Bridget G. Amy, Evan B. Krisch, Stacy J. Childs, Robert E. McCabe, E. James Seidmon, Ann T. Hurst, Allan L. Truant
Publikováno v:
Urology. 35(2)
Norfloxacin, a broad-spectrum antimicrobial analog of nalidixic acid, was evaluated by comparing it to trimethoprim-sulfamethoxazole in 93 office patients with recurrent urinary tract infections. In this prospective randomized study, norfloxacin and
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 42:302